Results 201 to 210 of about 14,685 (216)

Advancing Treatment of Degenerative Eye Diseases at the Nanoscale. [PDF]

Smart Med
Yao Jin L, Selvam EGP, Mei Q, Luu CD, Yap YHY, Teh DBL.   +5 more
europepmc   +1 more source

Safety profile of same-day bilateral intravitreal dexamethasone implantation for diabetic and uveitic macular edema: a single-center experience. [PDF]

BMC Ophthalmol
Kircali IK, Karti O, Ayhan Z, Utine CA, Arikan G, Saatci AO.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies

Drug Design, Development and Therapy, 2023
Georgios D Panos, Zisis Gatzioufas, Matteo Ripa   +2 more
exaly  

Intraocular implants loaded with AR agonist rescue retinal ganglion cells from ischemic damage

Journal of Controlled Release, 2022
Inês D Aires, Caridad Galindo-Romero, António Francisco Ambrósio   +2 more
exaly  

Comparison between “early” or “late” intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six-months follow-up

Cutaneous and Ocular Toxicology, 2017
Giuseppe La Torre, Fernanda Pacella, Elena Pacella   +2 more
exaly